[go: up one dir, main page]

BR9306399A - Composição farmacéutica para uso no tratamento de glaucoma - Google Patents

Composição farmacéutica para uso no tratamento de glaucoma

Info

Publication number
BR9306399A
BR9306399A BR9306399A BR9306399A BR9306399A BR 9306399 A BR9306399 A BR 9306399A BR 9306399 A BR9306399 A BR 9306399A BR 9306399 A BR9306399 A BR 9306399A BR 9306399 A BR9306399 A BR 9306399A
Authority
BR
Brazil
Prior art keywords
glaucoma
remedy
treatment
pharmaceutical composition
methoxyphenoxy
Prior art date
Application number
BR9306399A
Other languages
English (en)
Inventor
Takaaki Deguchi
Yoshifumi Ikejiri
Takahiro Ogawa
Katsuhiro Inada
Original Assignee
Senju Pharma Co
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co, Yamanouchi Pharma Co Ltd filed Critical Senju Pharma Co
Publication of BR9306399A publication Critical patent/BR9306399A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9306399A 1992-05-22 1993-05-19 Composição farmacéutica para uso no tratamento de glaucoma BR9306399A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13082892 1992-05-22
PCT/JP1993/000654 WO1993024121A1 (fr) 1992-05-22 1993-05-19 Medicament pour le glaucome

Publications (1)

Publication Number Publication Date
BR9306399A true BR9306399A (pt) 1998-09-15

Family

ID=15043659

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9306399A BR9306399A (pt) 1992-05-22 1993-05-19 Composição farmacéutica para uso no tratamento de glaucoma

Country Status (14)

Country Link
US (1) US5663205A (pt)
EP (1) EP0642789B1 (pt)
KR (1) KR100253515B1 (pt)
CN (1) CN1080849A (pt)
AT (1) ATE185070T1 (pt)
BG (1) BG62325B1 (pt)
BR (1) BR9306399A (pt)
CA (1) CA2136321A1 (pt)
DE (1) DE69326610T2 (pt)
ES (1) ES2137260T3 (pt)
HU (1) HUT71123A (pt)
RU (1) RU2102069C1 (pt)
TW (1) TW219930B (pt)
WO (1) WO1993024121A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
ID19891A (id) * 1996-08-02 1998-08-20 Senju Pharma Co Komposisi gangguan peredaran anti-okular
US6379688B2 (en) * 1997-02-28 2002-04-30 Senju Pharmaceutical Co., Ltd. Preservative for emulsion and emulsion containing same
US6036946A (en) 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
AU757896B2 (en) * 1998-09-02 2003-03-13 Allergan, Inc. Preserved cyclodextrin-containing compositions
US7708711B2 (en) 2000-04-14 2010-05-04 Glaukos Corporation Ocular implant with therapeutic agents and methods thereof
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
AU2002258754B2 (en) 2001-04-07 2006-08-17 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US7678065B2 (en) 2001-05-02 2010-03-16 Glaukos Corporation Implant with intraocular pressure sensor for glaucoma treatment
AU2002305400A1 (en) 2001-05-03 2002-11-18 Glaukos Corporation Medical device and methods of use for glaucoma treatment
US7331984B2 (en) 2001-08-28 2008-02-19 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
US7163543B2 (en) * 2001-11-08 2007-01-16 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US7951155B2 (en) 2002-03-15 2011-05-31 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US9301875B2 (en) 2002-04-08 2016-04-05 Glaukos Corporation Ocular disorder treatment implants with multiple opening
CA2506464C (en) * 2002-11-18 2012-07-31 Santen Pharmaceutical Co., Ltd. Therapeutic agent for glaucoma comprising rho kinase inhibitor and .beta.-blocker
KR20090082401A (ko) * 2006-10-31 2009-07-30 알콘 리서치, 리미티드 안 질환 치료용 pai-1 결합 조절제
EP2088976B1 (en) 2006-11-10 2019-07-03 Glaukos Corporation Uveoscleral shunt
CZ2009190A3 (cs) * 2009-03-30 2010-10-13 Ústav experimentální medicíny AV CR, v.v.i Zpusob merení lokální toxicity látek a zarízení k jeho provádení
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
EP3785683B1 (en) 2009-05-18 2023-11-01 Dose Medical Corporation Drug eluting ocular implant
EP2654715B1 (en) 2010-11-24 2017-01-25 Dose Medical Corporation Drug eluting ocular implant
EP2755549A1 (en) 2011-09-13 2014-07-23 Dose Medical Corporation Intraocular physiological sensor
US9163055B2 (en) * 2012-09-28 2015-10-20 Tufts University Methods for treating glaucoma using uridine diphosphate derivatives
US9730638B2 (en) 2013-03-13 2017-08-15 Glaukos Corporation Intraocular physiological sensor
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
WO2017184881A1 (en) 2016-04-20 2017-10-26 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3306820A (en) * 1966-03-18 1967-02-28 Barnes Hind Pharm Inc Ophthalmic composition containing an anesthetic and fluorescein sodium
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
JPS5495544A (en) * 1977-12-23 1979-07-28 Yamanouchi Pharmaceut Co Ltd Phenylethanolamine derivative and its preparation
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
JPS5746946A (en) * 1980-07-09 1982-03-17 Sandoz Ag 3-aminopropoxyphenyl derivative, manufacture and medicine containing same
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
FR2640969B1 (pt) * 1988-12-23 1991-11-22 Midy Spa
FR2642755B1 (pt) * 1989-02-07 1993-11-05 Sanofi
WO1994001096A1 (en) * 1992-07-02 1994-01-20 Telor Ophthalmic Pharmaceuticals, Inc. Methods and products for treating presbyopia

Also Published As

Publication number Publication date
EP0642789B1 (en) 1999-09-29
HU9403350D0 (en) 1995-02-28
BG99213A (bg) 1995-08-28
DE69326610T2 (de) 2000-06-08
CN1080849A (zh) 1994-01-19
HUT71123A (en) 1995-11-28
RU2102069C1 (ru) 1998-01-20
ES2137260T3 (es) 1999-12-16
KR100253515B1 (ko) 2000-05-01
DE69326610D1 (de) 1999-11-04
US5663205A (en) 1997-09-02
ATE185070T1 (de) 1999-10-15
RU94046143A (ru) 1996-09-27
TW219930B (pt) 1994-02-01
WO1993024121A1 (fr) 1993-12-09
BG62325B1 (bg) 1999-08-31
EP0642789A4 (pt) 1995-03-29
EP0642789A1 (en) 1995-03-15
CA2136321A1 (en) 1993-12-09

Similar Documents

Publication Publication Date Title
BR9306399A (pt) Composição farmacéutica para uso no tratamento de glaucoma
NO930817D0 (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
ATE170510T1 (de) 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
ES2138983T3 (es) Uso de derivados del acido 2-(n-(2-aminoetil)amino)-acetico para el tratamiento de enfermedades condicionadas por glicosilacion no enzimatica.
ATE78812T1 (de) Diarylverbindungen als antiatherosklerotische mittel.
DE69226370D1 (de) Parathyroidhormon enthaltene emulsion zur nasalen verabreichung
DK0630252T3 (da) Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
IE802135L (en) Pyrazolobenzodiazepines
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
FI101882B1 (fi) Herbisidiset [[(1,3,5-triatsin-2-yyli) aminokarbonyyli]aminosulfonyyli]bentsoehappoesterit, niitä sisältävä valmiste ja niiden käyttö
ATE108775T1 (de) N-phenyl-piperidyl-4-amine und diese enthaltende arzneimittel.
NO950177L (no) Farmakologisk aktive erivater
DE69118204D1 (de) Bekämpfung von parasitischen nematoden
EP0999209A4 (en) 2-sulfamoylbenzoic DERIVATIVES
DK347387A (da) Amidderivater
EP0666253A4 (en) N-T-BUTYLANILINE ANALOG CONNECTIONS AS LIPID LEVEL LOWERERS.
ES2076054T3 (es) Nuevas amino-alquil-cromonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO973122D0 (no) Middel for å minske okular spenning
IT1313583B1 (it) Derivati 2-amminotetralinici per la terapia del glaucoma.
ES8105146A1 (es) Un procedimiento para la preparacion de una solucion liquidainyectable de una sulfonamida
SE8402709D0 (sv) Stabiliserade flytande n-substituerade karbamatpreparat till anvendning som herbicider
IT1241928B (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
RU98109064A (ru) Глазные пленки
TH8676B (th) องค์ประกอบทางเภสัชที่ใช้ในการรักษาโรคต้อหิน

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal